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Abstract
Background: Upper limb dysfunction is common after stroke, posing an important challenge for post-stroke
rehabilitation. The clinical efficacy of acupuncture for the recovery of post-stroke upper limb function has been
previously demonstrated. Mirror therapy (MT) has also been found to be effective. However, the effects of acupuncture
and MT have not been systematically compared. This trial aims to elucidate the synergistic effects of acupuncture and
MT on upper limb dysfunction after stroke.
Methods: A 2 × 2 factorial randomized controlled trial will be conducted at the rehabilitation hospitals affiliated with
Fujian University of Traditional Chinese Medicine. A total of 136 eligible subjects will be randomly divided into acupuncture
treatment (AT), MT, combined treatment, and control groups in a 1:1:1:1 ratio. All subjects will receive conventional
treatment. The interventions will be performed 5 days per week for 4 weeks. AT, MT, and combined treatment will be
performed for 30 min per day (combined treatment: AT 15 min + MT 15 min). The primary outcomes in this study will
be the mean change in scores on both the FMA and WMFT from baseline to 4 weeks intervention and at 12 weeks
follow-up between the two groups and within groups. The secondary outcomes are the mean change in the scores
on the Visual Analogue Scale, Stroke Impact Scale, and modified Barthel index. Medical abstraction of adverse events
will be assessed at each visit.
Discussion: The results of this trial will demonstrate the synergistic effect of acupuncture and MT on upper limb motor
dysfunction after stroke. In addition, whether AT and MT, either combined or alone, are more effective than the
conventional treatment in the management of post-stroke upper limb dysfunction will also be determined.
Trial registration: Chinese Clinical Trial Registry: ChiCTR-IOR-17011118. Registered on April 11, 2017. Version
number: 01.2016.09.1.
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Background
Upper limb dysfunction is a common dysfunction after
stroke. Of 65–80% of patients with upper limb dysfunc-
tion, 37% have varying degrees of difficulty with upper
limb fine motor control [1]. Furthermore, approximately
50% are unable to complete activities of daily living
(ADL) independently 3 months after stroke onset [2].
Post-stroke upper limb dysfunctions, including coordin-
ation and execution problems of the arms, palms, and
fingers, cause limitations in eating, dressing, showering,
and other daily activities [3], increasing the financial bur-
den on families and society. Therefore, improving upper
limb dysfunction is a significant priority for stroke re-
habilitation so that patients can improve their abilities to
perform ADL and optimize their quality of life.
A variety of rehabilitation treatments are available for
upper limb dysfunction after stroke, including upper
limb motor training, adaptive equipment or aids, and
traditional Chinese medicine (TCM). However, manage-
ment of upper limb dysfunction after stroke is compli-
cated, and a single treatment is not adequate. Thus,
comprehensive multidisciplinary effective measures may
significantly improve the level of rehabilitation.
Currently, both acupuncture and mirror therapy (MT)
are widely used for stroke rehabilitation, with MT being
gradually applied by clinical researchers as a new treat-
ment for post-stroke limb rehabilitation [4–6], particu-
larly for severe upper limb and pain rehabilitation [7].
One study revealed that, after 1 month of MT, the func-
tional independence measure score increased from 52 ±
17.16 to 93.18 ± 22.07, the action research arm test
score increased from 15.90 ± 22.41 to 47.64 ± 15.19, and
the motricity index increased from 39.27 ± 27.33 to 76 ±
21.78. Therefore, compared to conventional treatment,
MT is a promising and simple method of improving
motor recovery of the upper limbs of subacute stroke
patients [8].
Acupuncture originated in ancient China approxi-
mately 2500 years ago as an important component of
TCM. It has been used for thousands of years in several
Asian countries to treat a variety of diseases. Acupunc-
ture is simple and effective and has no adverse drug re-
actions. It has become a popular topic in the field of
rehabilitation medicine in China. However, whether
acupuncture promotes recovery from stroke remains
controversial. Several studies have demonstrated that
acupuncture treatment (AT) may promote the recovery
of upper limb dysfunction after stroke [9–11]. One
study involving a post-hoc analysis showed that the
electrical stimulation group had greater improvements
in hand grip (P = 0.015) and pinch strength (P = 0.007)
than the control group after 4 weeks [12]. However, a
systematic review showed that the methodologic quality
of the included trials was inadequate and that the
results may not be reliable because of substantial het-
erogeneity [13].
Acupuncture is a state-of-the-art TCM treatment
widely utilized in China. The advantages of AT are its
simplicity, convenience, affordability, and efficacy. The
use of AT for the treatment of upper limb dysfunction
associated with stroke is in alignment with China’s
healthcare development priorities. Furthermore, MT is
an important component of modern Western rehabilita-
tion. The combination of AT and MT not only embodies
the combination of Chinese and Western medicine but
also reflects the integration of modern and traditional
rehabilitation. If the rehabilitation program is proven to
be effective, then its clinical effectiveness will be import-
ant for patients requiring rehabilitation. In addition, it is
unknown whether the outcomes of combined AT and
MT are superior to those of MT alone because very few
studies have compared the two therapies.
Therefore, we designed a 2 × 2 factorial randomized
controlled trial to explore the clinical efficacy of AT
combined with MT to improve the upper limb motor
function of stroke patients. We hypothesized that the
synergistic effect of both therapies is greater than the
sum of the individual effects of each intervention if they
are used separately. AT or MT significantly improved
upper limb function outcomes to a similar extent com-
pared with the control group.
During this trial, our first aim will be to assess the syn-
ergistic effects of AT and MT on the recovery of upper
limb function after stroke. Our second aim will be to de-
termine whether AT and MT, alone or in combination,
are more effective than conventional treatment for the
rehabilitation of upper limb dysfunction after stroke.
Methods
Study design and setting
This trial will use a 2 × 2 factorial randomized con-
trolled study to explore the clinical efficacy of AT com-
bined with MT for improving the upper limb motor
function of stroke patients. It will be performed in the
Rehabilitation Hospitals Affiliated with Fujian University
of Traditional Chinese Medicine (FJTCM). A total of
136 eligible subjects will be randomly divided into four
groups, namely (1) AT group, (2) MT group, (3) com-
bined treatment group (AT + MT), and (4) control
group, in a 1:1:1:1 ratio. All subjects will receive conven-
tional treatment, including health education and conven-
tional medical therapy. The interventions will be
performed 5 days per week for 4 weeks. AT, MT, and
combined treatment (AT 15 min + MT 15 min) will be
performed for 30 min per day. Therapists with more
than 5 years of clinical experience will perform the inter-
ventions. A 4-week intervention and 12-week follow-up
period will be conducted. Outcome measurements
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include the Fugl–Meyer Assessment for Upper Extrem-
ity (FMA-UE), Wolf Motor Function Test (WMFT), Vis-
ual Analogue Scale (VAS), Stroke Impact Scale (SIS),
Modified Barthel Index (MBI), and adverse events. The
flow diagram for this trial is presented in Fig. 1. The
undertaking unit of this project (the Rehabilitation
Hospitals Affiliated with FJTCM) and the ethics commit-
tees are responsible for making protocol decisions and for
communicating important protocol modifications. In
addition, the project undertaking unit is responsible for
coordinating the work of all departments (e.g., trial regis-
tries, researcher training, informed consent of the partici-
pants, data management). If there are important protocol
modifications, the project undertaking unit will notify
relevant parties to convene a coordination meeting.
Sample size
Sample size was calculated based on the improvement in
FMA-UE scores. Based on similar previous reports, the
mean difference and SD were 42.86 ± 3.74 and 41.68 ±
3.44 for AT and conventional therapy, respectively [14].
We expect an effect size of at least 0.3 for outcomes
after intervention. A sample size of 112 participants is
required to sufficiently detect a target effect size with a
type 1 error of 5% (α = 0.05) and 80% power (β = 0.20)
by using Gpower 3.1.9.2 software. Considering a 20%
attrition rate, a total of 136 participants are necessary,
with 34 participants in each group.
Participants and recruitment
We will recruit 136 eligible patients with upper limb
motor dysfunction caused by stroke from the rehabilita-
tion hospitals affiliated to FJTCM. Eligible patients must
meet the inclusion and exclusion criteria. A Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) Figure is shown in Fig. 2. Information
about this trial will be available through the hospital
website, and leaflets will be distributed to inpatients and
outpatients at multiple locations in the hospital. Inter-
ested patients can contact the project leader through
their therapists, among others, by telephone and e-mail.
If an applicant meets the study criteria, then they will be
invited to participate.
Inclusion criteria
Eligible patients are those (1) diagnosed with stroke and
confirmed by computed tomography or magnetic reson-
ance imaging; (2) first-ever clinical stroke occurred ≤ 6
months previously; (3) FMA-UE score of ≤ 33 points; (4)
modified Ashworth score of grade II or lower; (5) aged
between 18 and 80 years; (6) stable vital sign and
Fig. 1 Flow diagram of study design
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consciousness; and (7) provided written informed con-
sent to participate.
Exclusion criteria
Criteria for exclusion are (1) upper limb dysfunction
caused by brain tumor, brain trauma, and other diseases;
(2) Montreal cognitive assessment score ≤ 26 points (if
the education period is less than 12 years, then add 1
point to the score); (3) bone disease or joint damage
causing limb deformities; (4) serious disease in the heart,
liver, kidney, hematopoietic system, or endocrine system;
and (5) participation in other clinical trials that may
affect the results of this study.
Withdrawal criteria and management
Participants will be allowed, or required, to withdraw
from the trial based on (1) a major protocol violation;
(2) development of a serious disease preventing continu-
ation in the trial; (3) adverse events related to AT or
MT; and (4) request to be withdrawn from the trial.
Randomization and allocation
The randomization sequence will be created using SAS
9.1 by an independent statistician who works in the
Evidence-Based Medicine Center of FJTCM. The alloca-
tion of participants will be concealed using envelopes
that are sequentially numbered, opaque, and sealed.
Competent doctors will work in strict accordance with
the inclusion and exclusion criteria to determine
whether the subjects can participate in the study. The
investigator will then number the cases in chronological
order. Screeners will assign the eligible number and
opaque envelopes (containing random numbers and
Table 1 Groups and intervention allocation
Groups Interventions
Acupuncture treatment (AT) group Conventional treatment + AT
Mirror therapy (MT) group Conventional treatment + MT
Combination (AT + MT) group Conventional treatment + AT + MT
Control group Conventional treatment
Fig. 2 A Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure
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allocation and intervention information) to the thera-
pists. The treating therapists will be notified of the allo-
cation and make arrangements directly with the patient
to administer the allocated treatment. Eligible partici-
pants will be informed of their group allocation by the
project manager after their baseline information has
been assessed. Researchers who determined the random
numbers and performed the allocation will not partici-
pate in subject screening.
Blinding
A single-blind method will be used. The outcome asses-
sors, data manager, and statistics analyzer will evaluate
the results of the study without being aware of subject
allocation. The results of the assessment will be kept
confidential to the investigator, thereby improving the
accuracy of the test indicators, ensuring the effectiveness
of the interventions, and assuring the objectivity and re-
liability of the evaluation. Certain staff will supervise the
blind implementation process. The blind code will be
disclosed after completion of the statistical analysis.
Treatment allocation
The interventions will be performed 5 days per week for
4 weeks. AT and MT will be performed for 30 min per
day, and combined treatment (AT 15 min + MT 15 min)
will be performed for 30 min per day. During the study
period, precise documentation of treatments, medica-
tion, and lifestyle-related influencing factors will be
recorded in the case report forms (CRFs). All of the em-
ployees participating in this trial will receive standard-
ized training regarding the study protocol, treatment
methods, and assessments. The groups and intervention
allocation are listed in Table 1.
Conventional treatment
Basic treatment
All patients will receive conventional treatment provided
by the rehabilitation hospitals affiliated to FJTCM.
According to the Chinese prevention and treatment
guidelines of cerebrovascular disease [15], the doctors
will develop a basic treatment program based on the
specific characteristics of individual patients. This means
that patients will receive treatments deemed necessary
by the doctors, such as conventional medical treatment,
physical therapy, occupational therapy, and speech-
language therapy, while receiving intervention. There are
no restrictions for the aforementioned situations. We
will track the types of interventions provided and pre-
cisely document the therapy treatments and medication.
Health education
We will use health education manuals to perform health
education. The main contents of the manuals include (1)
the severity of stroke to encourage people to focus
enough attention and perform positive preventive mea-
sures actively; (2) the main risk and predisposing factors
for stroke and secondary stroke prevention; and (3)
management of and rehabilitation for stroke. For ex-
ample, the manual describes when the best time to see
the doctor is and how to cooperate with medical staff
during treatment and rehabilitation.
Mirror therapy
During initial treatment, the definition and content of
MT will be explained to patients by an occupational
therapist with more than 5 years of clinical experience.
Patients will be instructed to sit close to a table on
which a 35 × 35 cm mirror is vertically placed and then
to put the upper limbs on the table. The contralateral
upper limb will be positioned toward the reflective sur-
face of the mirror, and the ipsilateral upper limb will be
positioned on the opposite side of the mirror. Finally,
patients will be required to observe the movement of the
contralateral upper limbs in the mirror and to imagine
the affected side in motion. Then, they will be required
to perform the movement of the affected side as consist-
ently as possible (if patients cannot complete the move-
ment, then the experienced therapist will assist). Patients
will need to complete six movements, namely shoulder
flexion, elbow flexion and extension, forearm pronation,
wrist flexion and extension, finger stretching, and thumb
outreach. Patients will be asked to achieve a maximum
range of motion for 30 min per day for 5 days per week
for 4 weeks.
AT protocol
Participants will be treated using five acupuncture points
on the hemiplegia side (Jianyu [LI15], Quchi [LI11],
Shou sanli [LI10], Hegu [LI4], and Waiguan [TE5]) by
an acupuncturist with more than 5 years of clinical ex-
perience. AT will be performed with patients in the su-
pine position. Points will be sterilized with alcohol, and
the target position will then be fixed by the acupunctur-
ist’s left hand. The acupuncturist’s right hand will insert
the thin, disposable acupuncture needles (Huatuo, single
use, 0.30 × 40 mm; Suzhou HuaTuo Medical Instru-
ments, Suzhou, China).
The angle of insertion will be 10°–20° (between the
needle and skin), and the needle depth will be approxi-
mately 1.0–1.5 B-cun. Following insertion, stimulation of
the acupuncture point will be performed with bidirec-
tional rotation of the needle sleeve at approximately
18–300 per min to achieve the sensation known as Deqi,
which is commonly described as a glowing feeling.
The needle will be maintained in place for 30 min. A
sterilized, dry cotton ball will be gently pressed against
the point to prevent bleeding when each needle is
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withdrawn. The entire course of treatment will continue
for 30 min per day for 5 days per week for 4 weeks.
AT combined with MT
In the combined treatment group, patients will receive
AT (15 min) and MT (15 min). However, the two treat-
ments will be performed separately, yet the order of the
two treatment methods will not be limited. Each treat-
ment will last 15 min, for a total of 30 min per session.
Follow-up
All participants will participate in a 12-week unsuper-
vised follow-up period immediately after the end of
intervention. Telephone follow-up will be performed
once every 4 weeks, and records of the medications and
rehabilitation therapies will be kept. During the 6- and
12-week follow-up periods (10 weeks and 16 weeks after
intervention), participants will be referred for clinical
evaluation to assess their functional status, including
upper limb function, quality of life, and ADL.
Outcome assessment
The study period is 16 weeks. Outcomes will be assessed
at baseline, after 4 weeks of intervention, at 6-week
follow-up, and at 12-week follow-up. All outcomes will
be measured by several experienced assessors who are
blinded to the randomization group after the baseline
visit for evaluation. All assessors will be trained to ad-
minister these assessments.
Primary outcomes
The primary outcomes in this study are the mean
change in the scores on both the FMA and WMFT from
baseline to 4 weeks intervention and 12 weeks follow-up
between the two groups and within groups.
The FMA is widely used for motor function assessment
and can reflect the functional level of stroke subjects. Even
during the early stage of functional recovery, it can distin-
guish the level of motor function, particularly for those
who have low responsiveness. The upper extremity has a
maximum score of 66 points divided into three parts,
namely shoulder–arm (36 points), wrist–hand (24 points),
and coordination (6 points). The FMA-UE is the most
common scale for evaluating upper limb motor function
after stroke. It is often used as a gold standard for testing
the validity of other scales as well [16, 17]. The FMA-UE
has excellent reliability and validity and is sensitive enough
for clinical and research practice [18].
The WMFT is the preferred scale for assessing
mandatory exercise therapy for improving upper limb
functions. It can either assess the quality of the patient’s
completion of each activity or determine the time re-
quired for the patient to do so. The WMFT has good re-
liability and validity and high internal consistency [19].
Secondary outcomes
The mean change in the scores on the VAS, SIS, and
MBI after 4 weeks intervention are considered second-
ary outcomes.
In this study, the VAS will be used to evaluate the
highest overall pain level of the upper limb on the af-
fected side during the week before the assessment. The
basic method is to use a 10-cm horizontal line (one
marked with 10 scales, with endpoints “0” and “10”),
which allows patients to indicate the degree of pain.
Zero indicates no pain and 10 indicates the most intense
pain. In clinical practice, the VAS is considered the most
sensitive and reliable method for measuring pain [20].
SIS is mainly used to evaluate the impact of stroke on
the health and quality of life of patients [21]. The scale in-
volves items measuring dysfunction caused by stroke and
the impact on the patient’s life, with scores ranging from 0
to 100, and assesses the patients’ overall perceptions of re-
covery after stroke. The scale includes eight domains
(strength, hand function, ADL/instrumental ADL, mobile
ability, communication, mood, memory and thinking, and
participation) and has a total of 59 items.
MBI is the most commonly used internationally recog-
nized evaluation tool for testing the ability to perform
ADL [22]. This scale includes items related to bowel and
bladder continence, grooming, toileting, feeding, trans-
fer, walking, dressing, bathing, and going up and down
stairs. A normal score is 100, and lower scores indicate
greater dependency.
Safety assessments
Acupuncture may cause discomfort or bruising at the
sites of needle insertion, nausea, or feeling faint after
each treatment. No adverse reactions caused by MT
have been reported to date.
During the course of the study, any accidental injury
and sudden illness will be recorded. The degree of symp-
toms, time of occurrence, duration, and treatment will be
documented in the observation table. All adverse events
reported should be analyzed regardless of the investiga-
tors’ assessments of causality. Serious adverse events will
be reported to the ethics committee immediately.
Data collection and management
The data will be entered into a carefully designed elec-
tronic CRF. A dependent research assistant (RA) will be
in charge of quality control during the data collection
process. The project leader will be responsible for the
initial data cleansing, identification, coding, and conver-
sion to the appropriate data analysis format. In addition,
an independent data and safety monitoring board will be
established to monitor the safety of the trial. It will com-
prise two professional therapists who are experienced in
the rehabilitation of limb movement dysfunction after
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stroke and who are not directly involved in this study.
The data and safety monitoring board is independent
and will be responsible for the effectiveness and manage-
ment of data and reports of adverse events.
Demographic information, medical history and medi-
cation, lesions, affected side, handedness, cognitive func-
tion, time since stroke, stroke type, rehabilitation history
(treatment until the beginning of the study), details of
current and upper limb dysfunction treatment received
within the previous 3 months, and concomitant medica-
tions will be recorded. Data will be obtained through
direct questions to patients or a relative or proxy and
from medical records. The outcome measure will be per-
formed by an experienced assessor after intervention
and follow-up. All forms must be dated and signed by
the responsible investigator or one of the authorized
staff members.
The project manager will have access to the data, and all
data is treated with utmost confidentiality and made an-
onymous to anyone outside the study. All researchers in
this study will receive anonymous copies of all data in order
to promote dissemination of study results. The result of
our study will be published in a peer-reviewed journal.
Statistical analysis
All allocated subjects will be analyzed using the available
data (i.e., on the basis of the intention-to-treat). A mul-
tiple imputation method will be used to complete miss-
ing data. Continuous variables will be expressed as mean
(SD) for normal distribution or median for non-normal
distribution, and categorical variables will be expressed
as frequencies or percentages. A significance level of
95% (two-sided alpha P < 0.05) will be used.
After examining the data for normality (Kolmogorov–
Smirnov test), the outcome measures will be analyzed
using analysis of variance (assuming normal distribution)
or Kruskal–Wallis (non-parametric). Demographic char-
acteristics and other baseline values will be described
using descriptive statistics for each group. Intragroup
comparisons (changes in the FMA-UE, WMFT, VAS,
SIS, and MBI scores before and after treatment) will be
performed using the paired t test. The statistical signifi-
cance of the observed differences between the groups
will be assessed using 2 × 2 factorial analysis of variance
to test the main effect and interaction effects of the two
interventions (AT and MT). A statistician blinded to
study groups will conduct statistical analysis.
Quality control
 Quality control of informed consent: We will
randomly select 20% of the participants to
determine their knowledge about the study and
awareness of signed informed consent. If they are
knowledgeable, then this procedure will pass.
Otherwise, the trained RA will need to explain the
study again to all participants and randomly select
40% of the participants to determine their
knowledge. If they are knowledgeable, then the
procedure will pass; otherwise, the trained RA will
explain again.
 Quality control of participant screening: Participant
screening must be performed according to the
inclusion and exclusion criteria. If participants meet
all the criteria, then this procedure will pass. On the
contrary, participants who do not meet the criteria
will be excluded, and the number and reasons will
be recorded.
 Quality control of intervention: The project manager
will supervise the AT therapist and MT therapist
who will treat the participants, and the MT therapist
will supervise the intervention process of the
participants. At the same time, an independent
inspector will review the trial process, including the
treatment of the subjects, the procedures of the
therapist, and the registration of adverse events.
 Quality control of statistical analysis: Missing data
are not allowed in report forms, particularly for the
security index, which must be recorded clearly. Basic
demographic data, such as sex, date of birth, and
date of inclusion, among others, should be recorded
to distinguish between missing data. If the missing
data are left out after checking the original data,
then we need to complete the missing parts. If the
missing data are the security index, then we will not
record them in the original data for security;
rechecking of data will be necessary. The security
index will be removed if it affects the results.
 Quality control of data management: The project
manager will preserve and check all file lists. If
there are missing data, then related personnel will
be required to complete what is missing. Then, we
will randomly select 10% of the CRF to check
whether there any data errors. All data will be
independently double-entered into a computer.
The CRF questionnaire will be submitted to the
investigator via the clinical examiner for data auditing,
and the investigator should reply as soon as possible
thereafter.
Discussion
The incidence of upper limb dysfunction caused by
stroke can reach up to 66% [23]. Every year, approxi-
mately 70–80% of new patients lose their ability to work
to varying degrees and cannot take care of themselves,
placing a heavy burden on patients, families, and society
[24]. Upper limb motor dysfunction is a great challenge
during stroke rehabilitation.
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Studies have confirmed that direct current stimula-
tion, strength training, robot-assisted training, virtual
reality therapy, constraint-induced movement therapy,
and other rehabilitation therapies could achieve differ-
ent degrees of improvement about upper limb func-
tion after stroke [25–27]. Furthermore, AT and MT
seem to be beneficial for the recovery of upper limb
dysfunction after stroke [28, 29].
The effect of AT is mainly achieved by stimulating
acupuncture points called “acupoints,” which are spe-
cific parts of the body used to gather Qi and blood.
Acupoints are not only the external reactions of in-
ternal diseases in the body but also points for the treat-
ment of disease. The specific effect of AT on diseases is
mainly elicited through activating Qi and blood, as well
as balancing Yin and Yang [30]. AT can adjust the
upper limb meridians and help alleviate tendon stagna-
tion, which would eventually help the normalization of
the upper limb function.
MT is based on the mirror neuron system. It uses the
plane mirror imaging principle for the contralateral ac-
tivity images projected on the affected side. It also com-
bines optical illusions, visual feedback, and virtual reality
[31]. One study has further indicated that MT can pro-
mote the recovery of limb function after stroke, thereby
improving the ability to perform ADL [32].
However, the effects of AT and MT have not been sys-
tematically compared, and the possibility of a synergistic
effect of their combination has not been evaluated. There-
fore, we propose a rigorous, randomized, controlled clin-
ical trial to demonstrate that the two treatment methods
applied alone or in combination are more effective than
the conventional treatment. In this study, we will system-
atically evaluate the effects of different treatments on
upper limb motor dysfunction after stroke and assess the
upper limb motor function and daily activity. We will also
judge the long-term stability of improvements during a
12-week follow-up examination after intervention.
The major limitation of this protocol is its non-
double-blind design. However, the outcome assessors
and statistical analysts will be blind to the intervention
to decrease possible bias and ensure the quality of this
trial. This study also lacks long-term follow-up observa-
tions and assessments. The 4-week intervention cycle re-
flects its application in real-world clinical practice and is
sufficient to test whether the rehabilitation program is
effective in the short term.
In conclusion, the results of this study are expected to
elucidate the synergistic effects of AT and MT on upper
limb dysfunction after stroke. Furthermore, the results
are expected to confirm whether AT and MT, either
combined or alone, are more effective than conventional
treatment for the management of post-stroke upper limb
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